Europe’s healthcare biotech ‘stars’: How can we nurture them?

Healthcare biotech is a diverse sector, with 2,000 companies in Europe ranging from large multinational enterprises – with global annual sales exceeding €10 billion and annual research and development (R&D) expenditures of €1-€4 billion – to much smaller enterprises with fewer than ten employees and only grant-based income. It also includes hundreds of thousands of talented researchers, doctors and healthcare workers – all striving to push the frontiers of medical know-how.

To stimulate the discussion, we will be joined by two of the sector’s stars, Edwin Moses, CEO of Ablynx of Ghent and Jörn Aldag, CEO of Uniqure of Amsterdam, to hear their stories from the  ‘front lines’ of healthcare biotech. We will discuss with them how they got started, what obstacles they had to overcome, and what policy prescriptions their experiences might suggest. Other featured guests include Didier Schmitt, Scientific Adviser & Foresight Coordinator, European Commission and Rudolf Strohmeier, Deputy Director General, DG Research and Innovation, European Commission.

This event is by invitation only. Please contact [email protected]  if you are interested in participating.